UF Health Blood Cancers & Blood and Marrow Transplantation Program: Overview

Superior Care

The University of Florida Health Blood and Marrow Transplantation Program began in 1981, and is the state’s longest established transplant program. UF Health physicians have performed more than 3,500 transplants in adults and children for diseases such as leukemia, multiple myeloma, lymphomas, neuroblastoma, myelodysplastic syndromes, testicular cancer, aplastic anemia, certain genetic disorders and immunodeficiency syndromes.

Hear from our Director, Dr. John Wingard

Dr. John Wingard Interview

The Center for International Blood & Marrow Transplant Research reports our center’s one-year, risk-adjusted survival rate is among the top 2.5 percent for all transplant outcomes nationwide. We are one of only 15 centers in the country with this distinction.

Our program is the first in Florida to receive accreditation from the Foundation for the Accreditation of Cellular Therapy, and is one of only 20 core centers that make up the National Heart, Lung and Blood Institute/National Cancer Institute Blood and Marrow Transplant Clinical Trials Network.

The BMT program and Hematologic Malignancies Service offer inpatient and outpatient care for patients in the state-of-the-art UF Health Shands Cancer Hospital, and in collaboration with the UF Health Cancer Center, uses a multidisciplinary patient care approach that optimizes patient outcomes and satisfaction. Our program is consistently awarded a Five Star rating by Professional Research Consultants, a research firm that conducts health care satisfaction surveys, which ranks us among the top 10 percent in the nation for inpatient satisfaction.

UF Health successfully and routinely performs genetic cancer treatment to treat a broad variety of malignant and benign hematologic disorders, including among others:

First in Florida

  • 2017: Competitively selected as a core consortium of the NHLBI/NCI-funded Blood and Marrow Transplant Clinical Trials Network, one of only 12 centers selected in all 4 funding cycles
  • 2013: One of only five FDA-licensed public cord blood banks nationwide
  • 2012: Designated a Center of Excellence by the Myelodysplastic Syndromes Foundation, and as a referral center for the International Myeloma Foundation
  • 2008: Florida’s first haploidentical, or “half-match,” transplantation
  • 2000: Florida’s first accredited blood and marrow transplantation program
  • 1997: Florida’s first “mini” bone marrow transplantation for lymphoma
  • 1996: Florida’s first adult umbilical cord blood transplantation for leukemia
  • 1995: Florida’s first pediatric umbilical cord blood transplantation for leukemia
  • 1995: Nation’s third and the Southeast’s first umbilical cord blood bank
  • 1983: Florida’s first pediatric bone marrow transplantation